In this section you will find the releated documents your trust may need regarding the next Peer Review cycle. Click on the file to download to your PC
- UKFHD Overview Rpt 2025 - Good Practice Addendum
- UKFHD Overview Report November 2025
- Peer review 2023 - 2025 - Dr Emma Drasar
- UK Haemoglobin Disorders Peer Review Programme 2018-2020 - Subarna Chakravorty
- St George’s University Hospitals NHS Foundation Trust HD Report FINAL
- Cambridge University Hospitals NHS Foundation Trust HD Report FINAL
- West London Haemoglobinopathy Coordinating Centre Imperial College NHS Trust HD FINAL Report
- London North West University Healthcare NHS Trust HD Report FINAL
- Whittington HD FINAL Report - Whittington Health NHS Trust
- NMUH HD FINAL Report - North Middlesex University Hospital NHS Trust
- UHBW HD FINAL Report -South West Sickle Cell Haemoglobinopathy Coordinating Centre and University Hospitals Bristol and Weston NHS Foundation Trust
- TRCN UCLH HD Final Report - The Red Cell Network: Sickle Cell and Thalassaemia & Rare Inherited Anaemia Haemoglobinopathy Coordinating Centres
- Alder Hey HD FINAL Report 20240902
- Croydon HD FINAL Report 20240711
- GSTT HD FINAL Report 2024 07 11
- KCH HD FINAL Report 20240711
- Lewisham & Greenwich HD FINAL Report 2024 07 11
- Liverpool HD FINAL Report 2024 07 11
- MFT HD FINAL Report 20240711
- Newcastle HD FINAL Report 20240711
- Sheffield Children's Hospital NHSFT Report 01.02.24
- NE&Y HCC & STH HD report 2024 02 22
- Leeds Teaching Hospital NHST HD FINAL Report 2024 04 11
- Birmingham Women’s and Children’s NHSFT HD FINAL Report 20240919
- Nottingham University Hospitals NHST HD FINAL report 20241127
- Oxford University Hospitals NHSFT HD FINAL Report 20240919
- Sandwell & West Birmingham NHST HD FINAL Report 20240919
- University Hospital Southampton NHSFT HD FINAL Report 20241119
- University Hospitals of Leicester NHS Trust FINAL Report 20241127
Emma trained at St Barts and the Royal London School of Medicine, University of London and qualified in 2001 and is currently working as a Haematology Consultant between UCLH and the Whittington Hospital. She was Clinical Lecturer in Sickle Cell Disease at King’s College Hospital from 2009 to 2013 and during that time was awarded her PhD based on research into markers of severity and predictors of organ dysfunction in sickle cell disease. In 2013 she was awarded the Early Stage Investigator prize from the British Society of Haematology. She is the Haemoglobinopathy Coordinating Centre lead for North Central and West London, East Anglia and the South West and Central England.
John James OBE has 33 years of experience within the NHS including 4 CEO roles. He was Chair of the West London Cancer network (2002-2005) and Chair of the North West London Diabetes Network (2003-2004). 
Dr Subarna Chakravorty is a Paediatric Haematologist with a special interest in non-malignant haematology and stem cell transplant for haemoglobinopathy and non-malignant diseases. She joined King’s College Hospital as consultant in July 2015. Prior to that, Subarna led the Paediatric Haemoglobinopathy service at Imperial College Healthcare NHS Trust and the Imperial Paediatric Red Cell Disorders Network for 5 years, where she was also involved in the bone marrow transplant programme for paediatric haemoglobinopathy. Since 2021, Subarna has been involved in the adult sickle cell bone marrow transplant service at King’s College Hospital.
Dr Rachel Kesse-Adu is a consultant haematologist who qualified in medicine from Imperial College School of Medicine in 2002 and completed her specialist training in haematology at Kings College Hospital in London in 2012.